This website uses cookies to improve your experience. You can accept or reject analytics cookies
Gatavība Un Rīcība Infekcijas Slimības Izraisīta Apdraudējuma Un Ārkārtas Situācijas Gadījumā
Pandemic Preparedness and ResponseHealth Action Plan2026
LatviaSpanishPDF
National
AI-Generated Document Summary
Objectives
Latvia’s infectious-disease preparedness and response framework seeks to protect the population and maintain accessible, continuous healthcare during threats, emergencies and recovery by reducing transmission, limiting illness burden and safeguarding healthcare workers, patients and the public.It combines epidemiological safety, vaccination, clinical care, laboratory diagnosis, infection prevention and control, medical-resource management, public communication, and cross-border health measures.
Maintain and regularly update the State Disaster Medicine Plan and its infectious-disease preparedness annex, including the roles and functions of cross-sector planning bodies, legal provisions, institutional contacts, identified risks and lessons from incidents and exercises.
Strengthen surveillance, outbreak detection, case definitions, epidemiological investigation, contact tracing, laboratory testing and forecasting by using national and international information, including recommendations from the World Health Organization and the European Centre for Disease Prevention and Control.
Protect higher-risk groups, occupationally exposed people, children and the wider population through proportionate prevention, vaccination, isolation, quarantine, hygiene, distancing and anti-epidemic measures tailored to transmission routes, disease characteristics and epidemiological conditions.
Maintain essential, life-saving, emergency, inpatient, outpatient and vaccination services during health-sector emergencies, while adapting care pathways, hospital capacity and remote consultation arrangements where needed.
Build and sustain reserves of medicines, vaccines, sera, immunoglobulins, medical devices, personal protective equipment and laboratory supplies, with resource planning at national, sectoral and institutional levels.
Improve public and professional preparedness through clear, timely risk communication on disease threats, prevention, service changes, travel precautions, misinformation and emergency measures.
Support international travel and border measures that inform travellers, manage ill passengers, enable notification and contact tracing, and apply health measures according to the threat and local context.
Restore routine healthcare, surveillance, infection-control arrangements and resource stocks after emergency pressures decline, while reviewing the response and strengthening future preparedness.
Implementation
Implementation uses a phased, risk-based and cross-sector model, moving from preparedness to emergency response and recovery. Decisions draw on situation analysis, national surveillance, risk assessments and guidance from the World Health Organization, the European Centre for Disease Prevention and Control, the European Commission and other European Union institutions.The Ministry of Health coordinates the health-sector response alongside specialised public-health, emergency-care, health-financing, medicines, inspection, laboratory, municipal and healthcare bodies.
Activate emergency governance by notifying the Ministry of Health rapidly when a changed risk is identified, convening its emergency management group, and using the relevant health-sector commission to determine response measures, service changes and additional resource needs.
Coordinate participating institutions through the Ministry of Health, the Centre for Disease Prevention and Control, the Emergency Medical Service, the National Health Service, the Health Inspectorate, the State Agency of Medicines, municipalities, healthcare institutions, laboratories and other ministries or sectors.
Operate interoperable information exchange across public-health, healthcare, laboratory, supervisory, municipal, education, police, veterinary and other relevant institutions, including European Union and World Health Organization notification channels where applicable.
Mobilise workforce, facilities and equipment by identifying additional personnel, including students and external providers, reallocating beds, maintaining hospital disaster-medicine plans, and arranging specialised emergency teams, patient transport and hospitalisation flows.
Coordinate laboratory networks through capacity mapping, sample logistics, quality assurance, validation of tests for emerging infections, rapid reporting, national reference-laboratory investigation and arrangements with private laboratories for emergency testing.
Procure, store and distribute medicines, vaccines, equipment, personal protective equipment and testing materials centrally where required, assess reserve suitability and consider joint procurement and international assistance when domestic resources are insufficient.
Deliver vaccination by estimating vaccine requirements, planning logistics and service payment, identifying priority groups, recording administration and increasing coverage within available financial resources.
Communicate through trusted health representatives, daily media and website updates, press conferences, professional guidance and cooperation with European health-security communicators, while monitoring and addressing rumours and false information.
Monitor cases, outbreaks, hospital use, resource needs, laboratory capacity, legal compliance, infection-control implementation and adverse effects of medicines and vaccines; evaluate emergency measures and integrate surveillance into routine systems during recovery.
No consolidated quantitative indicator set, uniform evaluation methodology, formal accountability cycle or detailed monetary budget is specified across the supplied material.Resource and vaccination-service financing are instead linked to determined or allocated financial resources, while the framework emphasises stockholding, procurement and operational resource mobilisation.
Monitoring & Evaluation
The framework combines real-time epidemiological surveillance, laboratory reporting, resource monitoring, public communication and post-event review. It assigns operational monitoring duties to health institutions and public authorities, but does not establish a single quantitative indicator framework or unified independent accountability mechanism.
Monitor cases, outbreaks and transmission through notification, registration, analysis of surveillance data, epidemiological investigation, risk assessment, forecasting and use of international information from the World Health Organization, the European Centre for Disease Prevention and Control and European Union channels.
Use integrated digital systems for urgent case notifications, self-reporting questionnaires, infected-person and contact data, laboratory results, vaccination records, and information exchange among public-health, healthcare, laboratory, municipal, education, police and other relevant bodies.
Update infectious-disease case definitions in response to World Health Organization and European Centre for Disease Prevention and Control recommendations, and review surveillance arrangements as the epidemiological situation changes.
Investigate outbreaks, identify contacts, arrange environmental and contact-person testing, and reassess the scope and frequency of epidemiological investigations and related interventions within one day where specified.
Monitor laboratory capacity, testing availability, sample logistics, test quality and validation for newly emerging infections; provide timely test reporting and refer selected samples to the national reference laboratory for further examination.
Record hospitalised patients, transfers and deaths, including at least 24-hourly recording of hospitalisations and deaths through links between the National Health Service and the Emergency Medical Service.
Monitor inpatient capacity, additional staffing requirements, medical-resource reserves, medicine stocks, equipment readiness and the suitability of reserved resources.
Monitor adverse effects of medicines and vaccines through pharmacovigilance cooperation between the State Agency of Medicines and the Centre for Disease Prevention and Control.
Supervise compliance with hygiene, infection-control, anti-epidemic, medical-device and pharmaceutical requirements through the Health Inspectorate and other competent bodies, using risk-based oversight where appropriate.
Provide rapid situation reporting to the Ministry of Health and crisis-management bodies, including initial risk assessments, numbers of affected people, resource requirements and information on cross-sector involvement.
Exchange new information under the preparedness annex within one hour where required, notify the Ministry of Health within one hour of a changed risk situation, and convene the Ministry’s emergency management group within two hours.
Maintain daily public and media monitoring, publish at least daily updates on developments in Latvia, the European Union and globally, and communicate health-sector decisions through coordinated public information channels.
Review laws, institutional contacts and preparedness arrangements at least annually; use exercises, training and information exchange to test and improve readiness.
Evaluate control measures, emergency restrictions, resource use and the wider emergency response during recovery, and assess whether the State Disaster Medicine Plan and its preparedness annex require improvement.
Continue routine surveillance after an emergency to identify renewed outbreaks, pathogen mutations and antimicrobial resistance, while maintaining outbreak investigation and routine infection-control measures.
Recognise that the material does not specify consolidated quantitative performance indicators, targets, standard reporting templates, audit procedures, a common evaluation methodology or a dedicated formal accountability cycle.
Costing & Financing
Financing provisions focus on resource preparedness, procurement and service payment rather than on a costed implementation plan. The material provides no overall budget, monetary allocation, funding gap, funding source, economic assumption or costing methodology for the infectious-disease preparedness and response measures.
Plan, centrally procure, store and distribute medicines, vaccines, serums, immunoglobulins, medical devices, personal protective equipment, laboratory equipment, supplies, reagents and testing materials according to the situation and identified health-sector needs.
Assess available state, sectoral and institutional resources, update resource-request and distribution arrangements, and mobilise additional staff, equipment and premises when a health-sector emergency requires them.
Review reserve medical resources, medicine stocks, planned deliveries and additional procurement requirements during a threat, and collect information on remaining stocks and options for replenishment during recovery.
Maintain medicine stocks equivalent to three months’ consumption for inpatient healthcare institutions and one month’s consumption for closed-type outpatient pharmacies and the Emergency Medical Service; these are stockholding requirements, not monetary budget allocations.
Plan payment for vaccination services, including tariffs and relevant reimbursable or recorded procedures, within the financial resources determined, approved or allocated.
Use joint procurement at European Commission level where applicable, and seek international assistance under the State Civil Protection Plan annex when domestic service organisation or procurement cannot meet national needs.
Recognise that laboratory capacity, emergency testing, training, mortuary storage, refrigerated containers, workforce mobilisation and healthcare support are identified resource needs without associated monetary values.